Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
JEJonathan E. RosenbergJHJean Hoffman‐CensitsTPTom PowlesMSMichiel S. van der HeijdenAVArjun Vasant Balar
Memorial Sloan Kettering Cancer Center · Sidney Kimmel Cancer Center · +34 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
3,707
total citations
- FWCI
- 491.52
- Percentile
- 100%
- References
- 58
Citations per year
Authors
31- JEJonathan E. RosenbergCorresponding
Memorial Sloan Kettering Cancer Center
- JHJean Hoffman‐Censits
Sidney Kimmel Cancer Center, Thomas Jefferson University
- TPTom Powles
Barts Health NHS Trust, Queen Mary University of London, University College London, The Royal Free Hospital
- MSMichiel S. van der Heijden
The Netherlands Cancer Institute
- AVArjun Vasant Balar
NYU Langone Health
Topics & keywords
Topics
Keywords
- Atezolizumab
- Metastatic Urothelial Carcinoma
- Medicine
- Response Evaluation Criteria in Solid Tumors
- Oncology
- Internal medicine
- Population
- Chemotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.